- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Draf III in Korea, Democratic People's Republic of
Total 118 results
-
Yonsei UniversityCompleted
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingStage II Colon Cancer | Stage III Colon CancerKorea, Republic of
-
Seoul National University HospitalUnknownProstate Cancer Recurrent | Stage II Prostate Carcinoma | Stage III Prostate CarcinomaKorea, Republic of
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | BRAF V600EKorea, Republic of
-
Yonsei UniversityUnknownNon-DM Stage II High-risk Colorectal Cancer | Non-DM Stage III Colorectal CancerKorea, Republic of
-
Samsung Medical CenterRecruitingBreast Cancer Stage IIIKorea, Republic of
-
Samsung Medical CenterCompletedLocally Advanced Stage III or IV Thymic CancerKorea, Republic of
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Chungnam National University HospitalBoryung Pharmaceutical Co., LtdEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Samsung Medical CenterCompletedCuratively Resected Stage III Colon CancerKorea, Republic of
-
Yonsei UniversityCompletedMandibular Retrognathism | Mandibular PrognathismKorea, Republic of
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
AstraZenecaCompletedStage II HypertensionKorea, Republic of
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Pusan National University HospitalPusan National University Yangsan HospitalUnknownElective Surgery of Gastrointestinal Tract | 100 Adults Aged Between 20 and 70 Years Old | ASA Physical Status of I or IIKorea, Republic of
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIBKorea, Republic of
-
Samsung Medical CenterUnknownStage IIIA Non-small Cell Lung CancerKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
BayerCompleted
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
HucircadianPusan National University Hospital; Korea University Guro Hospital; Korea University... and other collaboratorsRecruitingMajor Depressive Disorder | Bipolar 1 Disorder | Bipolar II DisorderKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedDyslipidemia | Type II DiabetesKorea, Republic of
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Samsung Medical CenterUnknownNasophayngeal Carcinoma Between Stage II and IVbKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Green Cross CorporationCompleted
-
Green Cross CorporationCompleted
-
Green Cross CorporationUnknownThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) PatientsHunter SyndromeKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
CanariaBio Inc.Korean Cancer Study GroupRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO StageKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of